We are proud to announce that our proposal, "Galenic 360° - Compounding as an Integrated Digital Service for Personalized Care", was awarded 1st place at the Innovation Competition of the 17th Pancretan Pharmaceutical Conference.

What is Galenic 360° ?

Galenic 360° is a vision for the future of personalized pharmaceutical care. Its goal is to transform pharmaceutical compounding, from a standalone preparation process into a comprehensive healthcare service.

The concept combines:

• Personalized compounded therapies
• Digital patient support and follow-up
• Treatment outcome monitoring
• Enhanced collaboration between pharmacists, patients and healthcare professionals
• Continuous, patient-centered pharmaceutical care

Why does it matter?

Healthcare is increasingly moving toward personalization. Pharmaceutical compounding has always been one of the most powerful tools for individualized treatment, and we believe it can play an even greater role in the future of patient care.

Galenic 360° proposes a model in which compounding extends beyond the preparation itself, incorporating follow-up, support, and optimization of the patient's therapeutic journey.

A recognition that inspires us to move forward

This award is a meaningful recognition of our vision for a more modern, scientific, and patient-centered pharmacy.

We would like to thank the organizing committee of the 17th Pancretan Pharmaceutical Conference, the Pharmaceutical Association of Heraklion, and everyone who supports innovation in healthcare.

At Cocoon Lab, we believe that the future of pharmacy lies in personalization, collaboration, and the thoughtful use of technology to improve patient outcomes.

The next chapter is just beginning!

Proposal Team:

Eva Mitsaki, Eirini Chondrou